Speaker illustration

Doctor Byung Ho Lee

Korea Research Institute of Chemical Technology, Daejeon (Korea (Republic of))

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

Event: ESC Congress 2016

Topic: Chronic pulmonary hypertension

Session: Basic mechanisms in pulmonary hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb